Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Mar;57(3):253-62.
doi: 10.1046/j.1365-2125.2003.02004.x.

Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria

Te-Yu Hung  1 , Timothy M E Davis, Kenneth F Ilett, Harin Karunajeewa, Sean Hewitt, Mey Bouth Denis, Chiv Lim, Doung Socheat
Affiliations

Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria

Te-Yu Hung et al. Br J Clin Pharmacol. 2004 Mar.

Abstract

Aims: To study the population pharmacokinetics of piperaquine after co-administration with dihydroartemisinin in uncomplicated malaria.

Methods: The disposition of piperaquine was studied in 85 Cambodian patients with uncomplicated falciparum or vivax malaria treated with the piperaquine-dihydroartemisinin coformulation Artekin. All patients were given Artekin orally at 0, 6, 24 and 32 h with a total piperaquine dose of 32-35 mg base kg-1. Adults were given tablets while children received either tablets or a dispersible granule formulation. Patients underwent either intensive (17-19 samples) or sparse (2-5 samples) blood sampling schedules over 35 days and clinical/parasitological follow-up over > 28 days. Piperaquine in plasma was quantified by high performance liquid chromatography.

Results: All patients achieved fever clearance within 24 h and parasite clearance within 72 h. The 28-day cure rate was 97% in adults and 98% in children. A covariate-free two-compartment population model with first-order absorption and elimination gave the most robust representation of the plasma concentration-time data in both adults and children. In adults (n = 38), the median (interquartile range) derived pharmacokinetic descriptors CL/F, Vss/F and t1/2,z were 0.9 l h-1 kg-1 (0.79-1.02 l h-1 kg-1), 574 l kg-1(371-711 l kg-1) and 23 days (19-28 days), respectively. In children (n = 47), corresponding values were 1.8 l h-1 kg-1 (1.29-2.3 l h-1 kg-1), 614 l kg-1 (332-1205 l kg-1) and 14 days (10-18 days), respectively.

Conclusions: Piperaquine is a highly lipid-soluble drug with a large Vss/F, long t1/2,z and a clearance that is markedly higher in children than in adults.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Piperaquine phosphate – 1,3-bis[1-(7-chloro-4′-quinolyl)-4′-piperazinyl] phosphate
Figure 2
Figure 2
Plots of weighted residuals against predicted piperaquine concentrations for datasets from (A) adults and (B) children. Residuals were approximately evenly distributed above and below zero (solid line). Homoscedastic and heteroscedastic weighted error models were used for the adult and children datasets, respectively
Figure 3
Figure 3
Observed plasma piperaquine concentration-time data for adults (A) and children (B). The solid lines show simulated concentration-time data (solid line) derived from the mean pharmacokinetic parameters (Table 5) and the average doses (Table 2). The dotted line indicates the assay limit of quantification (LOQ; 5 µg l−1). Note that concentrations below the LOQ do not contribute to the regression analysis. The biphasic appearance of the simulated curves within the first 3 days results from the close proximity of doses 1 and 2, and 3 and 4 (see Methods)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chen L, Qu FY, Zhou YC. Field observations on the antimalarial piperaquine. Chin Med J (Engl) 1982;95:281–6. - PubMed
    1. Chen L. Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine. Chin Med J (Engl) 1991;104:161–3. - PubMed
    1. Fan B, Zhao W, Ma X, et al. In vitro sensitivity of Plasmodium falciparum to chloroquine, piperaquine, pyronaridine and artesunate in Yuxi prefecture of Yunnan province. Chin J Parasitol Parasit Dis. 1998;16:460–2. - PubMed
    1. Lan CX, Lin X, Huang ZS, Chen YS, Guo RN. In vivo sensitivity of Plasmodium falciparum to piperaquine phosphate assayed in Linshui and Baisha counties, Hainan Province. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1989;7:163–5. - PubMed
    1. Yang H, Liu D, Huang K, et al. Assay of sensitivity of Plasmodium falciparum to chloroquine, amodiaquine, piperaquine, mefloquine and quinine in Yunnan province. Chin J Parasitol Parasit Dis. 1999;17:43–5. - PubMed

Publication types